Searchable abstracts of presentations at key conferences in endocrinology

ea0063p13 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Pheochromocytoma – 3 sides of the same story

Ene Cristina , Nour-Dinca Angelica , Acatrinei Eliza , Casian Marioara , Enyedi Mihaly , Terzea Dana , Istrate Adrian , Grozavu Constantin

Background: Pheochromocytomas are rare tumors, with prevalence less than 0.2% of hypertensive patients, in general population being unknown. With increasing access to imaging and hormonal workup, more pheochromocytomas are diagnosed. This may have changed the occurrence of the classic presentation with hypertension and the classic triad.Methods: We present 3 cases of pheochromocytoma diagnosed in our departments over the last 2 years, with 3 different ph...

ea0049ep792 | Endocrine tumours and neoplasia | ECE2017

Chronic stress and somatotroph axis in breast cancer more than a simple association

Crumpei Iulia , Armasu Ioana , Danciu Mihai , Tofan Mariana , Volovat Constantin , Belceanu Alina , Crumpei Felicia , Adomnicai Valentina , Vulpoi Carmen

Introduction: Epidemiological and clinical studies have proven direct correlations between chronic stress, inflammation and cancer progression. The inflammatory environment preexisting the malignant change and elevated IGF-1 levels are associated with higher cancer risk, especially through GH effects on cell proliferation and inhibition of apoptosis.Aim: To evaluate the relationship between biological and hormonal stress markers, growth factors and breas...

ea0049ep809 | Obesity | ECE2017

Obesity, gonadotropic axis and breast cancer – is ghrelin the connexion?

Armasu Ioana , Crumpei Iulia , Volovat Constantin , Tofan Mariana , Zaharia Valentin , Aancutei Adrian , Vasiliu Ioana , Lacramioara Serban Ionela , Vulpoi Carmen

Introduction: Obesity and insulin resistance have been identified as risk factors for breast cancer and are associated with late-stage diagnosis and poor prognosis. Ghrelin is a unique gut-derived peptide that has major impact in energy homeostasis and weight regulation, with new emerging implications in tumorigenesis process, especially in hormone-dependent cancers.Aim: To evaluate the relationship between ghrelin, clinico-biological parameters of obesi...

ea0047oc6 | Spotlight on Neuroendocrine tumours | Theranostics2016

DNA damage assay in blood lymphocytes in peptide receptor radionuclide therapy patients with personalised high activities

Eberlein Uta , Scherthan Harry , Werner Rudolph A , Lapa Constantin , Bluemel Christina , Peper Michel , Buck Andreas K , Port Matthias , Lassmann Michael

Objectives: Radiation induces DNA double strand breaks (DSBs) that can be visualized and enumerated as microscopic γ-H2AX and 53BP1 foci. This study analysed the dose- and time-dependency of the DNA damage in blood lymphocytes in patients after a personalised high-activity 177Lu-DOTATATE treatment.Methods: We investigated multiple blood samples of three patients up to 96 h after personalised high-activity peptide receptor radionuclid...

ea0037ep81 | Adrenal cortex | ECE2015

Acute adrenal insufficiency as a first sign of metastatic pulmonary carcinoma

Manolachie Adina , Volovat Constantin , Grigorescu Cristina , Botnariu Gina Eosefina , Gafton Bogdan , Armasu Ioana , Leustean Letitia , Vulpoi Carmen

Introduction: Adrenal glands are common sites for secondary lesions derived from malignant tumours (lymphoma, melanoma, renal, breast, colon, and bronchopulmonary cancer). Patients with adrenal secondary lesions are typically asymptomatic but 1% may present with adrenal insufficiency as a first manifestation. We report the cases of two males with lung adenocarcinoma, first presented with acute adrenal insufficiency.Cases presentation: Case 1: LC, 65 year...

ea0037ep1343 | Clinical Cases–Thyroid/Other | ECE2015

Concomitance of pancreatic and neuroendocrine breast tumour – simple coincidence or not?

Crumpei Iulia , Fadur Alina , Manolachie Adina , Zmau George , Anton Mihaela , Volovat Constantin , Ungureanu Maria Christina , Vulpoi Carmen

Introduction: Breast neuroendocrine carcinoma is a rare aggressive neuroendocrine tumour (NET) and the research on this subject is poor. Only seven studies were cited in the literature. Incidence in the population has not been reported, but the prevalence is under 0.1% of all breast carcinomas.Case report: AV, 72, is hospitalised for bone pain and significant weight loss (15 kg in 2 months). Patient’s previous history are: diabetes, hypertension, no...

ea0035p592 | Endocrine tumours and neoplasia | ECE2014

Pancreatic neuroendocrine tumour with a silent long evolution: case report

Manolachie Adina , Crumpei Felicia , Volovat Constantin , Bodescu Ioana , Idriceanu Jeanina , Vasiliu Ioana , Fadur Alina , Preda Cristina , Vulpoi Carmen

Pancreatic neuroendocrine tumors (pNET) represent 1.3% of pancreatic tumours, ~65% patients presenting with metastatic/unresectable disease. Clinically, pNET may be asymptomatic, accompanied by carcinoid syndrome or abdominal pain.Patient N.A. aged 73, with a history of hemorrhagic pancreatitis, was diagnosed in 2003 with a hyperechoic heterogeneous solid pancreatic tumour of 28/28 mm. No therapy/monitoring were proposed. After 7 years of asymptomatic ev...

ea0089t8 | Trials In Progress | NANETS2022

Phase II Trial Evaluating [177Lu]Lu-DOTA-TATE in Adolescents with Somatostatin Receptor (SSTR)-positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), Pheochromocytomas and Paragangliomas (PPGLs)

Chauhan Aman , Sue O'Dorisio M. , Gaze Mark , Sabado Constantino , Brouri Fazia , Xu Lingfei

Background: GEP-NETS and PPGLs in pediatric patients are rare; however, recognition of these diseases has increased recently. 10–20% of pediatric patients with GEP-NETs and up to 47% of pediatric patients with PPGLs present with metastatic disease at diagnosis. The disease is often unresectable with poor prognosis, and very few non-surgical therapies are approved for these patients. Due to paucity of data surrounding treatments for pediatric patients with advanced GEP-NET...

ea0032n2 | (1) | ECE2013

Psychiatric morbidity in pediatric patients after surgical remission of Cushing’s disease: case presentations

Keil Margaret , Ryder Celia , Stratakis Constantine

Context: Endogenous Cushing’s syndrome (CS) may have different effects in children than what has been described in adults. Prior studies of children and adolescents with CS have identified cognitive decline despite reversal of brain atrophy after remission of CS, as well as residual impairment in quality of life measures. Although the observations of parents of children and adolescents with CS support personality changes, significant psychopathology has not been described...

ea0090p490 | Thyroid | ECE2023

Challenges in the management of endocrine complications after hematopoietic stem cell transplantation – could it be reconstitution Graves’ disease?

Grosu Iustina , Dumitrache Sabina-Maria , Stan Raluca , Zubaci Ana , Iliescu Marina , Tarna Mihaela , Jercan Cristina , Colita Anca , Nicoleta Cima Luminita , Fica Simona

Background: The rapid advancements in the field of allogenic hematopoietic stem cell transplantation (allo-HSCT) and better management of acute postprocedural complications have led to increased life expectancy, but at the same time to higher incidences of long-term complications. Conditioning regimens (chemotherapy, total body irradiation), immunosuppresive treatments and immune dysregulation threaten endocrine and metabolic functions, leading to late effects, including hypog...